Prof. Ehab Said Ibrahim Eldesoky
Assiut university, Egypt

Email: ehegypt@yahoo.com

Qualifications
1994   M.D., Assiut University, Pharmacology
1989   M.Sc., Assiut University, Pharmacology
1984   M.B., Tanta University, Medicine

Publications (Selected)

1. Ehab S. EL Desoky, Eman. M. Khedr, Mohamed. S. Khalil  and Thomas Gasser. Genetic Analysis of Leucin-Rich Repeat Kinase 2 (LRRK2) G2019S Mutation in a Sample of Egyptian Patients with Parkinson's Disease, a Pilot Study. British Journal of Medicine & Medical Research 2015, 5 (3): 404-408.
2. Ehab S. EL Desoky. The AMPA receptor antagonist perampanel is a new hope in the treatment for epilepsy. Fundamental and Clinical Pharmacology. 2014; 28 (5): 473-80.
3. Ehab S. EL Desoky. Mohamed H Ghazal, Rajendra P Singh, Omnia N Abdelhamid , Hartmut Derendorf . Population Pharmacokinetics of Methotrexate in Egyptian Children with Lymphoblastic Leukemia. Pharmacology and Pharmacy. 2013; 4: 139-145.
4. E. S. EL Desoky, S. N. Sabarinath,  M. M. Hamdi,  M. Bewernitz and H. Derendorf.  Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.  Journal of Clinical Pharmacy and Therapeutics, 2012, 37, 352–355.
5. Ehab S. ELDesoky. Drug therapy of heart failure. An immunological view. Am JTher. Accepted for publication in December 2009 (Review).
6. Ehab S. ELDesoky, Sherif I. Kamel, Ahlam M. Farghaly, Madiha Y. Bakheet, Mohsen A. Hedaya and Jean-Pascal Siest. Study of the urinary ratio of 6 β-hydroxycortisol/cortisol as abiomarker of CYP3A4 activity in Egyptian patients with chronic liver disease. Drug Target Insights 2006, 2: 157-164.
7. Ehab S. ELDesoky, Ihab A. Fouad. Pharmacological Evidence for the Role of Nitric Oxide-cGMP in antinociception.The Journal of Applied Research 2005; 5: 451-59.
8. Ehab EL Desoky Mahmoud R. Kandil, Abdel-Halim M. Afifi, and Ossama M. Mostafa. Spotlight on the continual applicability of routine plasma monitoring antiepileptic drugs in the treatment of epilepsy.Pharmacol Res 1999;39: 269-274.
9. Ehab S.ELDesoky, Ahlam M. Ahmed, Mohamed A Nafeh, Hanan Abd EL-Aty Ahmed, Ekkehard Schutz, Victor W. Armstrong and Michael Oellerich. Assessment of liver function by the MEGX test in patients with schistosomiasis and cirrhosis. Clin Biochem 1999;32: 207-212.
10. Ehab S.ELDesoky, Asmaa H Shoreit. Once versus twice daily administration of amikacin in pediatric patients with bronchopneumonia: plasma drug concentration and Bayesian pharmacokinetic estimation. Ann Pharmacother. 1999;33:749-750.
11. Raymond G. Morris; Benedetta C. Sallustio; Alexander A. T. M. M. Vinks; Donald F. LeGatt; Zulfikarali H. Verjee; Ehab El Desoky. Some international approaches to aminoglycoside monitoring in the extended dosing interval era. Ther Drug Minit 1999; 21: 379-388.
12. Ehab ELDesoky , Mohammed MA Khalifa, Jehan A Mahmoud, Salwa AT Ebraheemand U Klotz.Disposition and clinical efficacy of methotrexate in patients with rheumatoid arthritis following weekly low intramuscular dosing: a pilot study. Curr Ther Res 1997; 58: 434-445.
13. Ehab El Desoky E, Mohamed H Ghazal, Moussa A Mohamed, Ulrich Klotz.Disposition of intravenous theophylline in asthmatic children: Bayesian approach vs. Direct pharmacokinetic calculations.Jpn J Pharmacol 1997; 75: 13-20.
14. U. Gladziwa, S. Wagner, K. V. Dakshinamurty , E. ElDesoky , B. Dreuw , and U. Klotz .Pharmacokinetics and pharmacodynamics of famotidine in patients with reflux oesophagitis.Eur J Clin Pharmacol 1993; 44: 357-360.
15. E. ELDesoky and U Klotz. Value, limitations, and clinical impact of therapeutic drug monitoring in adults. Drug Invest 1993; 6: 127-136.